Literature DB >> 1413992

Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide.

P A Cane1, D A Matthews, C R Pringle.   

Abstract

Respiratory syncytial virus strains (subgroup A) isolated from around the world during the period 1988-1991 were analysed to determine their relatedness. Analysis was by restriction mapping and nucleotide sequencing following amplification of selected regions of the virus genome by polymerase chain reaction (PCR). Twenty-three viruses of subgroup A isolated from cities in temperate regions of the Northern and Southern hemispheres and the tropics during the period 1988-1991 fell into distinct groupings closely related to four of the six lineages defined in analysis of recurrent epidemics within the same city (Birmingham, UK) during the same period. These observations confirm that multiple lineages of RS virus co-circulate locally, and show that very similar viruses are present simultaneously in widely separated countries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413992     DOI: 10.1016/0168-1702(92)90096-r

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  23 in total

1.  Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene.

Authors:  Alfonsina Trento; Inmaculada Casas; Ana Calderón; Maria L Garcia-Garcia; Cristina Calvo; Pilar Perez-Breña; José A Melero
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.

Authors:  W B Coggins; E J Lefkowitz; W M Sullender
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  Molecular characterization of an outbreak of respiratory syncytial virus (subgroup A) in Havana, Cuba, by monoclonal antibodies and restriction mapping (N gene).

Authors:  A Valdivia; D Chacón; C Savón; S Oropesa; L Sarmiento; O Valdes; A Otero; D Rosario; A Goyenechea
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 4.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Respiratory syncytial virus--how soon will we have a vaccine?

Authors:  G L Toms
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

6.  Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wild-type strains of respiratory syncytial virus.

Authors:  H Zheng; T C Peret; V B Randolph; J C Crowley; L J Anderson
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.

Authors:  H Plotnicky-Gilquin; L Goetsch; T Huss; T Champion; A Beck; J F Haeuw; T N Nguyen; J Y Bonnefoy; N Corvaïa; U F Power
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein.

Authors:  P A Cane; C R Pringle
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children.

Authors:  R Mentel; U Ilgert; U Wegner; K Zimmerman; R Bruns; L Gürtler
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

10.  Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.

Authors:  Viviane F Botosso; Paolo M de A Zanotto; Mirthes Ueda; Eurico Arruda; Alfredo E Gilio; Sandra E Vieira; Klaus E Stewien; Teresa C T Peret; Leda F Jamal; Maria I de M C Pardini; João R R Pinho; Eduardo Massad; Osvaldo A Sant'anna; Eddie C Holmes; Edison L Durigon
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.